Peripheral T- and natural killer-cell lymphomas: ESMO–EHA Clinical Practice Guideline for diagnosis, treatment and follow-up
Francesco d’Amore(Aarhus University), Mats Jerkeman(Skåne University Hospital), Gerald Wulf(University of Göttingen), Massimo Federico(University of Modena and Reggio Emilia), François Lemonnier(Université Paris-Est Créteil), Fredrik Ellin(Landstinget i Kalmar län), Olivier Hermine(Centre National de la Recherche Scientifique), Joost S.P. Vermaat(Leiden University), Laurence de Leval(University Hospital of Lausanne), Woo Seob Kim(Samsung Medical Center), M. Dreyling(Ludwig-Maximilians-Universität München), Christian Buske(University Hospital Ulm)
Cited by 12
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2017|736
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|604
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|568